G. Alan Robison

6.0k total citations · 6 hit papers
57 papers, 4.6k citations indexed

About

G. Alan Robison is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Alan Robison has authored 57 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Physiology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Alan Robison's work include Adenosine and Purinergic Signaling (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Adipose Tissue and Metabolism (5 papers). G. Alan Robison is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Adipose Tissue and Metabolism (5 papers). G. Alan Robison collaborates with scholars based in United States, Czechia and Canada. G. Alan Robison's co-authors include Earl W. Sutherland, R.W. Butcher, John H. Exton, J. Michael Schmidt, Gene C. Palmer, C.R. Park, Paul E. Langley, Dennis E. Schmidt, J. G. Hardman and Fridolin Sulser and has published in prestigious journals such as Science, The Lancet and Journal of Biological Chemistry.

In The Last Decade

G. Alan Robison

56 papers receiving 4.1k citations

Hit Papers

Some Aspects of the Biological Role of Adenosine 3',5'-mo... 1965 2026 1985 2005 1968 1967 1966 1971 1965 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Alan Robison United States 31 2.2k 1.2k 1.0k 649 592 57 4.6k
Theodore W. Rall United States 28 3.7k 1.7× 1.4k 1.2× 1.6k 1.6× 869 1.3× 609 1.0× 49 6.8k
Ronald N. Rubin United States 37 3.3k 1.5× 887 0.8× 1.7k 1.7× 676 1.0× 870 1.5× 154 6.0k
George I. Drummond Canada 38 2.9k 1.3× 841 0.7× 642 0.6× 257 0.4× 309 0.5× 101 4.5k
G. Schultz Germany 45 5.0k 2.3× 1.4k 1.2× 2.1k 2.1× 397 0.6× 450 0.8× 118 7.0k
Thomas P. Douša United States 41 2.8k 1.3× 532 0.5× 489 0.5× 351 0.5× 389 0.7× 181 5.2k
J. Adolfo García‐Sáinz Mexico 37 3.7k 1.7× 1.2k 1.0× 1.6k 1.6× 595 0.9× 653 1.1× 239 5.4k
H. O. Schild United Kingdom 30 3.6k 1.7× 2.0k 1.7× 2.1k 2.1× 243 0.4× 413 0.7× 84 7.1k
L E Limbird United States 36 3.0k 1.4× 579 0.5× 1.8k 1.8× 275 0.4× 409 0.7× 60 4.4k
R.W. Butcher United States 31 4.5k 2.1× 2.1k 1.8× 1.6k 1.6× 1.1k 1.8× 991 1.7× 65 8.8k
Nobuyuki Yanagihara Japan 34 1.9k 0.9× 1.2k 1.1× 1.0k 1.0× 325 0.5× 345 0.6× 183 4.2k

Countries citing papers authored by G. Alan Robison

Since Specialization
Citations

This map shows the geographic impact of G. Alan Robison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Alan Robison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Alan Robison more than expected).

Fields of papers citing papers by G. Alan Robison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Alan Robison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Alan Robison. The network helps show where G. Alan Robison may publish in the future.

Co-authorship network of co-authors of G. Alan Robison

This figure shows the co-authorship network connecting the top 25 collaborators of G. Alan Robison. A scholar is included among the top collaborators of G. Alan Robison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Alan Robison. G. Alan Robison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robison, G. Alan, et al.. (1994). PWR reactor coolant system license renewal industry report; revision 1. Final report. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
2.
Rosenfeld, Gary C., Samuel J. Strada, & G. Alan Robison. (1979). Cyclic nucleotides and the central effects of opiates: an overview of current research.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20. 261–79. 9 indexed citations
3.
Burns, Thomas W., Boyd E. Terry, Paul E. Langley, & G. Alan Robison. (1977). In-vitro Observations on Isolated Adipose Tissue Cells from Hyperobese Subjects. Diabetes. 26(7). 657–662. 4 indexed citations
4.
Clement‐Cormier, Yvonne C., Jerrold J. Heindel, & G. Alan Robison. (1977). Adenylyl cyclase from a prolactin producing tumor cell: The effect of phenothiazines. Life Sciences. 21(9). 1357–1363. 19 indexed citations
5.
Sanders, R., W. J. Thompson, & G. Alan Robison. (1977). Epinephrine- abd glucagon-stimulated cardiac adenylyl cyclase activity. Biochimica et Biophysica Acta (BBA) - General Subjects. 498(1). 10–20. 39 indexed citations
6.
Burns, Thomas W., Paul E. Langley, & G. Alan Robison. (1975). Site of free-fatty-acid inhibition of lipolysis by human adipocytes. Metabolism. 24(3). 265–276. 40 indexed citations
7.
Greengard, Paul & G. Alan Robison. (1973). Adenyl cyclase ; Cyclic nucleotide phosphodiesterases ; Protein kinase substrares ; Cyclic GMP ; The chemistry and biological properties of nucleotides related to nucleoside 3' 5' -cyclic phosphates ; Clinical studies and applications of cyclic nucleotides. Raven Press eBooks. 1 indexed citations
8.
Palmer, Gene C., Fridolin Sulser, & G. Alan Robison. (1973). Effects of neurohumoral and adrenergic agents on cyclic amp levels in various areas of the rat brain in vitro. Neuropharmacology. 12(4). 327–337. 99 indexed citations
9.
Greengard, Paul, G. Alan Robison, & Rodolfo Paoletti. (1972). New assay methods for cyclic nucleotides. Raven Press eBooks. 3 indexed citations
10.
Greengard, Paul, G. Alan Robison, & Rodolfo Paoletti. (1972). Physiology and pharmacology of cyclic AMP. Raven Press eBooks. 19 indexed citations
11.
Palmer, Gene C., et al.. (1972). DEVELOPMENT AND CHARACTERISTICS OF THE HISTAMINE‐INDUCED ACCUMULATION OF CYCLIC AMP IN THE RABBIT CEREBRAL CORTEX. Journal of Neurochemistry. 19(10). 2251–2256. 37 indexed citations
12.
Robison, G. Alan, et al.. (1972). THE EFFECT OF NEONATAL THYROIDECTOMY ON THE DEVELOPMENT OF THE ADENOSINE 3′,5′‐MONOPHOSPHATE SYSTEM IN THE RAT BRAIN. Journal of Neurochemistry. 19(4). 937–947. 30 indexed citations
13.
14.
Robison, G. Alan, Gabriel G. Nahas, & L Triner. (1971). Cyclic AMP and cell function. New York Academy of Sciences eBooks. 21 indexed citations
15.
Palmer, Gene C., G. Alan Robison, & Fridolin Sulser. (1971). Modification by psychotropic drugs of the cyclic adenosine monophosphate response to norepinephrine in rat brain. Biochemical Pharmacology. 20(1). 236–239. 40 indexed citations
16.
Singhal, Radhey L., et al.. (1971). Metabolic control mechanisms in mammalian systems. Involvement of adenosine 3′:5′-cyclic monophosphate in androgen action. Biochemical Journal. 125(1). 329–342. 27 indexed citations
17.
Robison, G. Alan. (1970). Cyclic AMP as a second messenger.. PubMed. 10. 55–74. 15 indexed citations
18.
Robison, G. Alan & Earl W. Sutherland. (1970). Sympathin E, sympathin I, and the intracellular level of cyclic AMP.. PubMed. 27(1 Suppl 1). 147–61. 41 indexed citations
19.
Sutherland, Earl W. & G. Alan Robison. (1969). The Role of Cyclic AMP in the Control of Carbohydrate Metabolism. Diabetes. 18(12). 797–819. 173 indexed citations breakdown →
20.
Butcher, R.W., G. Alan Robison, J. G. Hardman, & Earl W. Sutherland. (1968). The role of cyclic AMP in hormone actions. Advances in Enzyme Regulation. 6. 357–389. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026